Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
One consideration unique to covering GLP-1s for anti-obesity is that while plan sponsors will incur new short-term pharmacy costs, expected cost offsets such as lower medical benefit costs may not materialize until years later
Remember all three of these medications contain the same ingredientsemaglutide
Laboratory research record on GLP-1S [PMID: 29907893] PubMed laboratory record discussing GLP-1S in a research context
Oral formulations are anticipated to gain faster acceptance among patients seeking non-injectable options for long-term therapy use
US$ 29.02
US$ 29.88
US$ 23.42
US$ 22.78
US$ 25.61
